NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)☆
Cisplatin-based chemotherapy is the standard treatment of choice for head and neck squamous cell carcinoma (HNSCC). The efficiency of platinum-based therapies is directly influenced by the development of tumor resistance. Multiple signaling pathways have been linked to tumor resistance, including ac...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Elsevier
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907686/ |